Jan. 27, 2010 – Victoza (liraglutide), a drug intended to help lower blood sugar levels along with diet, exercise, and selected other diabetes medicines, was approved on January 25 for a once-daily injection to treat type 2 diabetes in some adults..
Liraglutide Gets FDA Approval As New Treatment For Type 2 Diabetes Senior Journal
Related posts:
- R Receives FDA Approval For Adults With Type 2 Diabetes Marketwire PRINCETON, NJ–(Marketwire – January 26, 2010) – Novo Nordisk (...
- R Receives FDA Approval For Adults With Type 2 Diabetes Medical News Today Novo Nordisk (NVO) announced that the U.S. Food and Drug...
- R Liraglutide For The Treatment Of Type 2 Diabetes Medical News Today Novo Nordisk announced that the US Food and Drug Administration...
- R Liraglutide For The Treatment Of Type 2 Diabetes Marketwire Via Yahoo Finance BAGSVæRD, DENMARK–(Marketwire – 01/25/10) – Novo Nordisk announced today that...
- New Treatment For Type 2 Diabetes Approved By FDA The U.S. Food and Drug Administration approved Victoza (liraglutide), a...
